Indicated for active immunisation of individuals from 2 months of age and older against invasive meningococcal disease caused by Neisseria meningitidis group B
Is there a need for meningitis B private vaccination?
GSK has created a series of short videos exploring the burden of the disease, at risk group and in depth look at GSK meningitis B vaccine, Bexsero.
Meningitis B - epidemiology, signs and symptoms.
Who are the patients at risk in the UK?
Overview of Bexsero.